De Novo Protein Design with AI

AI protein design for creating and optimizing de novo proteins using advanced machine learning models for biotech and life science applications. Part of our Molecular Design service.


Key R&D Challenges in Protein Design
We Solve with AI

Higher hit probability per experimental round

  • Reducing experimental burden by prioritizing high-likelihood functional variants before synthesis

Avoiding constructs that misfold or fail purification

  • Identifying stable, soluble, and expressible protein designs prior to wet-lab validation

Guiding rational design of modulators and biologics

  • Mapping and prioritizing therapeutically relevant PPI interfaces for inhibition or stabilization

Lowering manufacturing and formulation risks

  • Detecting early signs of aggregation, degradation pathways, or structural instability

De-risking IND-enabling work

  • Predicting immunogenic and liability-prone sequence regions before preclinical studies

Reducing downstream liabilities early

  • Ranking antibody or binder variants using joint affinity, specificity, and developability scores

Faster progression to IND candidates

  • Accelerating lead optimization by modeling potency, developability, and manufacturability simultaneously

Have a specific AI protein design or PPI modeling challenge in mind?

Share your target, interaction context, and available data. We’ll evaluate whether AI-driven protein design, PPI modeling, or hybrid physics-ML methods are applicable — and recommend an approach grounded in what can be modeled reliably.

Case Studies

AI Drug Discovery Platform Using Multi-Omics Data

The team surpassed expectations on timelines, provided much needed guidance and overall input on design, all while operating with a high degree of autonomy.

Carl Kaub

Vice President of Chemistry at HTG Molecular Diagnostic

Biotech

Industry

AI Ops & MLOps, Cloud Architecture, UI/UX Design

Services

USA

Location

$200,000 to $999,999

Budget

10×

Larger Variant Screening Space

AI expands search into billions of virtual sequences, uncovering high-potency candidates unreachable through traditional directed evolution or rational design alone.

70%

Fewer Wet-Lab Iterations

Predictive models surface top variants early, allowing teams to order fewer constructs while achieving higher success rates in the first experimental round.

2–3×

Higher Hit Quality

PPI and stability models improve potency, specificity, and developability – drastically reducing downstream attrition.

>95%

Prediction Accuracy

Sequence-to-structure and PPI predictions optimized for biologics lead to more reliable ranking and fewer dead-end constructs.

5×

Faster Lead Optimization

From target → candidate → optimized variant in weeks, not quarters — accelerating path to IND-enabling studies.

FAQ

Questions R&D teams ask

01What is AI protein design?

It uses generative models, such as diffusion and transformer architectures, to create new protein sequences and scaffolds, together with models that predict structure, stability, binding and developability. Candidates are ranked in silico, so the lab only synthesizes the most promising variants.

02Which protein modalities do you work with?

Antibodies, enzymes, cytokines, fusion proteins, scaffolds and synthetic binding proteins. Models are tailored to the modality and to the properties that matter for it.

03Which models do you use?

AlphaFold-class, Boltz-family and OpenFold3-grade structure prediction, deep-learning models for protein–protein interactions and binding affinity, and generative models for de novo sequences. We pick methods, including hybrid physics-ML approaches, based on what can be modeled reliably for your target.

04How does AI protein design work with our wet lab?

We deliver ranked variant lists and feed assay results back through your ELN or LIMS, so each design–test cycle improves the models. The aim is fewer constructs per round and earlier removal of variants likely to misfold, aggregate or fail developability.

Let’s build your AI advantage

Whether you’re prototyping a molecule scoring system or looking to automate your clinical ops – we’ll help you turn your biotech data into competitive edge.

Case Studies

AI-Powered Solutions
 We Delivered